Our Services
Medical Information
Helpful Resources
Published on: 1/9/2026
Gemtesa (vibegron) is a prescription medicine used to treat overactive bladder in adults, reducing sudden urinary urgency, frequent urination, leakage, and nighttime urination by relaxing the bladder muscle. There are several factors to consider, including who is a good candidate, how quickly it works, possible side effects, and safety considerations; see the complete details below to guide your next steps.
What Is Gemtesa Used For?
Gemtesa (generic name: vibegron) is a prescription medication approved to treat symptoms of overactive bladder (OAB) in adults. OAB is a common condition characterized by a sudden urge to urinate, frequency (needing to go often), and sometimes leakage (urge urinary incontinence). Gemtesa belongs to a class of drugs called β3-adrenoceptor agonists and works by relaxing the bladder muscle, helping it hold more urine and reducing the urge to go.
Gemtesa is prescribed for adults who experience one or more of the following OAB symptoms:
Gemtesa may be considered when behavioral interventions (e.g., bladder training, fluid management) are not sufficient alone.
A pivotal study by Seki et al. (2018) evaluated the efficacy and safety of vibegron (Gemtesa) in adults with OAB:
Key findings:
These results support Gemtesa as an effective and well-tolerated option for OAB.
Most people tolerate Gemtesa well. Common side effects observed in clinical trials include:
Most side effects were mild to moderate. If any side effect feels severe or does not go away, contact your healthcare provider.
Before starting Gemtesa, tell your doctor if you:
Gemtesa is not recommended for children under 18. Always follow your doctor's dosing instructions.
Combining Gemtesa with lifestyle changes can further improve OAB symptoms:
While Gemtesa is generally safe, certain situations require prompt medical evaluation:
If you experience any of these, seek medical care right away.
If you're experiencing urgency, frequency, or other bladder concerns and want to better understand whether your symptoms may indicate overactive bladder, try Ubie's free AI-powered overactive bladder symptom checker to get personalized insights before your next doctor's visit.
This information is not a substitute for professional medical advice. Always speak to your doctor or a qualified healthcare professional about:
If you suspect a serious or life-threatening condition, seek immediate medical attention.
Talk to your doctor to determine if Gemtesa is the right treatment for your overactive bladder and to develop a comprehensive plan tailored to your needs.
(References)
Seki N, Hattori K, Takahashi S, Kishida S, Agawa T, Watanabe T. (2018). Efficacy and safety of vibegron, a β3-adrenoreceptor agonist… Int J Urol, 29182164.
Ripoll C, Groszmann RJ, Garcia-Tsao G, Bosch J, Grace ND, Burroughs AK, Planas R, Garcia-Pagán JC. (2007). Hepatic venous pressure gradient predicts development… Journal of Hepatology, 17848471.
Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. (2016). Portal hypertension and variceal bleeding: unresolved issues… Journal of Hepatology, 27393628.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.